Latest news, press releases, and SEC filings for Kalaris Therapeutics Inc (KLRS) https://caymanjournal.com/stock/KLRS en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 03:41:48 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is an **S-3 registration statement**, essentially a "permission slip" from the SEC. It allows specific existing shareholders of Kalaris Therapeutics to sell their shares to the public on the open market. Think of it as the company facilitating a secondary sale, not ra https://caymanjournal.com/stock/KLRS/sec-filing/0001193125-26-142151 https://caymanjournal.com/stock/KLRS/sec-filing/0001193125-26-142151 Fri, 03 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is an **S-3 filing** with the SEC, specifically containing an **Indenture** for **subordinated debt securities**. Think of it as the master rulebook the company will follow if it decides to issue corporate bonds (IOUs) to investors in the future. It doesn't issue any https://caymanjournal.com/stock/KLRS/sec-filing/0001193125-26-142199 https://caymanjournal.com/stock/KLRS/sec-filing/0001193125-26-142199 Fri, 03 Apr 2026 00:00:00 GMT SEC Filing